Overview

Effect of Urtica Dioica on Glycemic Control in Patients With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
0
Participant gender:
All
Summary
Diabetes mellitus is the most common metabolic disorder worldwide. Some herbs are traditionally used in treatment of type 2 diabetes mellitus (T2DM). Urtica Dioica (UD) or stinging nettle is traditionally used in Morocco, Turkey, Brasil, Jordan and with much frequency in northern Iran. Studies on animal models along with in vitro studies has shown hypoglycemic effect for aqueous extract of UD. This study aimed to investigate hypoglycemic effects of UD tea bags in patients with T2DM on glycemic control, insulin sensitivity, along with its effects on lipid profile (LP), blood pressure (BP), liver, and kidney function.
Phase:
Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Criteria
Inclusion Criteria:

- Clinical diagnosis of T2DM

- Must be able to drink UD or Placebo tea bags 3 times every day

Exclusion Criteria:

- Insulin dependent diabetes

- History of congestive heart failure within last 5 years (NYHA Class III-IV)

- History of significant pulmonary disease, myocardial infarction, cerebrovascular
accident, or nephrotic syndrome within last 1 year

- Thyroid disease

- Known renal or hepatic insufficiency

- Gastric problem

- History of UD or and other herb use in past 6 months

- Pregnancy or lactation

- Use of any herbal or supplement within past 6 months

- Use of an investigational drug (within 30 days prior to enrollment)

- Known maternal allergies

- Dumping syndrome